|
000
| 02149cam 2200349za 4500 |
|---|
| 001 | 9.832845 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107150058 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 170222s2017 onc ob f000 0 eng d |
|---|
| 022 | |z1925-0878 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH113-9/2017-1E-PDF|zH113-9/2017-1E |
|---|
| 245 | 00|aNicarbazin |h[electronic resource]. |
|---|
| 260 | |aOttawa : |bHealth Canada, Pest Management Regulatory Agency, |c2017. |
|---|
| 300 | |a41 p. |
|---|
| 490 | 1 |aProposed registration decision, |x1925-0886 ; |vPRD2017-01 |
|---|
| 500 | |aIssued also in French under title: Nicarbazine. |
|---|
| 500 | |aCover title. |
|---|
| 500 | |a"3 February 2017.” |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 520 | |a"Health Canada’s Pest Management Regulatory Agency (PMRA), under the authority of the Pest Control Products Act and Regulations, is proposing full registration for the sale and use of Nicarbazin (technical product), 30% Granulated Nicarbazin Premix (manufacturing concentrate), and OvoControl P (commercial class end-use product), containing the technical grade active ingredient nicarbazin, to reduce feral pigeon populations. An evaluation of available scientific information found that, under the approved conditions of use, the product has value and does not present an unacceptable risk to human health or the environment. This Overview describes the key points of the evaluation, while the Science Evaluation provides detailed technical information on the human health, environmental and value assessments of Nicarbazin, 30% Granulated Nicarbazin Premix, and OvoControl P”--Overview, p. 1. |
|---|
| 530 | |aIssued also in print format. |
|---|
| 692 | 07|2gccst|aPesticides |
|---|
| 692 | 07|2gccst|aCertification |
|---|
| 692 | 07|2gccst|aToxicology |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |
|---|
| 710 | 1 |aCanada. |bPest Management Regulatory Agency. |
|---|
| 775 | 08|tNicarbazine |w(CaOODSP)9.832847 |
|---|
| 830 | #0|aProposed registration decision,|x1925-0886 ; |vPRD2017-01|w(CaOODSP)9.504464 |
|---|
| 856 | 40|qPDF|s372 KB|uhttps://publications.gc.ca/collections/collection_2017/sc-hc/H113-9/H113-9-2017-1-eng.pdf |
|---|